UnitedHealth Group Incorporated - UNH

UNH Returns vs S&P 500 ⓘ

ticker	1 day return %	1 week return %	1 month return %	3 months return %	6 months return %	1 year return %	3 years return %	5 years return %	10 years return %	maximum return %
UNH	-0.5	-0.6	6.6	1.1	21.7	10.4	34.7	118.6	500.4	418657.4
S&P 500	0.0	0.8	5.6	9.4	14.5	32.4	33.3	95.6	191.7	34157.5

Compare UNH with other assets →

Returns Charts ⓘ

Interactive Price Chart

Our interactive price chart includes various drawing tools to help you analyze the product more effectively. Below is a quick guide on how to use these tools: Full Guideline

Real-time Full Quote

Attribute	Value
symbol	UNH
name	UnitedHealth Group Incorporated
price	605.23
changes percentage	-0.54
change	-3.29
day low	604.82
day high	615.53
year high	630.73
year low	436.38
market cap	556983485320
price avg 50	585.39
price avg 200	536.35
exchange	NYSE
volume	1677216
avg volume	3210658
open	610.85
previous close	608.52
eps	15.38
pe	39.35
earnings announcement	2025-01-10T13:30:00.000+0000
shares outstanding	920284000
timestamp	2024-12-03 21:00:02

Financial Statements ⓘ

We derive the score of a company's financial statements by evaluating the weighted average sentiment across key within the statements. The cumulative score, normalized to a sum of 1, serves as a metric for assessing the company's performance during the specified period. A higher score indicates stronger performance. However, it's crucial to note that while this score provides valuable insights, it is just one of many factors to consider when making informed investment decisions. A holistic evaluation, considering various aspects of the company's financial health and market conditions, is essential for a well-rounded investment strategy.

Overall Annual Financial Health: 66.0%

Overall Quarterly Financial Health: 73.3%

Income Statements ⓘ

• Annual Income Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000731766
revenue	367533000000	322132000000	14.09
gross profit	86869000000	77587000000	11.96
gross profit ratio	0.24	0.24	-1.87
research and development expenses	0	0	NaN
operating expenses	54511000000	51182000000	6.50
interest income	0	0	NaN
interest expense	3246000000	2092000000	55.16
ebitda	32517000000	31835000000	2.14
ebitdaratio	0.09	0.09	-4.38
operating income	32358000000	28435000000	13.80
operating income ratio	0.09	0.09	-0.26
net income	22381000000	20120000000	11.24
net income ratio	0.06	0.06	-2.50
eps	24.12	21.54	11.98

Overall Score of Annual Income Statement

0.86 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Revenue Growth: revenue increased to 367,533 million in 2023 from 322,132 million in 2022 representing a change of 14.09%. This indicates a sales growth, which is a positive sign for the company.

  Gross Profit: Gross Profit increased to 86,869 million in 2023 from 77,587 million in 2022 representing a change of 11.96%. This indicates a sales profitability growth, which is a positive sign for the company.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) increased to 32,517 million in 2023 from 31,835 million in 2022 representing a change of 2.14%. The increase in EBITDA indicates improved operational efficiency and profitability.

  Operating Income: Operating income increased to 32,358 million in 2023 from 28,435 million in 2022 representing a change of 13.8%. The increase in operating income indicates better operational performance and increased profitability.

  Net Income: Net income increased to 22,381 million in 2023 from 20,120 million in 2022 representing a change of 11.24%. The increase in net income shows improved profitability and indicates that the company is generating more profit for each dollar of revenue.

  Earnings per Share (EPS): EPS increased to 24.12 in 2023 from 24.12 in 2022 representing a change of 11.98%. This indicates that the company's earnings are increasing and it is becoming more profitable on a per-share basis.

• 📉 Negative Indicators

  Operating Expenses: Operating Expenses increased to 54,511 million in 2023 from 51,182 million in 2022 representing a change of 6.5%. The increase in operating expenses can be attributed to various factors such as marketing, administrative costs, and investments in infrastructure. It's important to monitor if these expenses are growing at a sustainable rate compared to revenue.

• Quarterly Income Statement

Note: The years below are fiscal years in accounting.

	2024Q3	2024Q2	Q/Q change %
0000731766
revenue	100820000000	97858000000	3.03
gross profit	23029000000	21060000000	9.35
gross profit ratio	0.23	0.22	6.14
research and development expenses	0	0	NaN
operating expenses	12678000000	14182000000	-10.60
interest income	0	0	NaN
interest expense	1074000000	985000000	9.04
ebitda	9729000000	7670000000	26.84
ebitdaratio	0.1	0.08	19.56
operating income	8708000000	7875000000	10.58
operating income ratio	0.09	0.08	7.33
net income	6055000000	4216000000	43.62
net income ratio	0.06	0.04	39.40
eps	6.56	4.58	43.23

Overall Score of Quarterly Income Statement

0.86 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Revenue Growth: revenue decreased to 100,820 million in 2024Q3 from 97,858 million in 2024Q2 representing a change of 3.03%. This indicates a sales shrinking, which is a negative sign for the company.

• 📈 Positive Indicators

  Gross Profit: Gross Profit increased to 23,029 million in 2024Q3 from 21,060 million in 2024Q2 representing a change of 9.35%. This indicates a sales profitability growth, which is a positive sign for the company.

  Operating Expenses: Operating Expenses decreased to 12,678 million in 2024Q3 from 14,182 million in 2024Q2 representing a change of -10.6%. The decrease in operating expenses can be attributed to various factors such as improved profitability, cost optimization and financial stability, lower operating expenses can be positive indicators.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) increased to 9,729 million in 2024Q3 from 7,670 million in 2024Q2 representing a change of 26.84%. The increase in EBITDA indicates improved operational efficiency and profitability.

  Operating Income: Operating income increased to 8,708 million in 2024Q3 from 7,875 million in 2024Q2 representing a change of 10.58%. The increase in operating income indicates better operational performance and increased profitability.

  Net Income: Net income increased to 6,055 million in 2024Q3 from 4,216 million in 2024Q2 representing a change of 43.62%. The increase in net income shows improved profitability and indicates that the company is generating more profit for each dollar of revenue.

  Earnings per Share (EPS): EPS increased to 6.56 in 2024Q3 from 6.56 in 2024Q2 representing a change of 43.23%. This indicates that the company's earnings are increasing and it is becoming more profitable on a per-share basis.

Balance Sheets ⓘ

• Annual Balance Sheet

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000731766
total assets	273720000000	245705000000	11.40
total liabilities	174801000000	159358000000	9.69
total equity	98919000000	86347000000	14.56
cash and cash equivalents	25427000000	23365000000	8.83
short term investments	4201000000	4546000000	-7.59
long term investments	0	43728000000	-100.00
total current assets	78437000000	69069000000	13.56
total non current assets	195283000000	176636000000	10.56
total current liabilities	99054000000	89237000000	11.00
total non current liabilities	80442000000	70121000000	14.72
common stock	9000000	9000000	0.00
retained earnings	95774000000	86156000000	11.16
total debt	62537000000	57623000000	8.53

Overall Score of Annual Balance Sheet

0.56 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Total Assets: Total Assets increased to 273,720 million in 2023 from 245,705 million in 2022 representing a change of 11.4%. Suggesting a growth in asset holdings.

  Total Equity: Total Equity increased to 98,919 million in 2023 from 86,347 million in 2022 representing a change of 14.56%. This indicates an increase in shareholders' equity.

  Cash And Cash Equivalents: Cash And Cash Equivalents increased to 25,427 million in 2023 from 23,365 million in 2022 representing a change of 8.83%. This indicates an increase in available liquid assets.

  Total Current Assets: Total Current Assets increased to 78,437 million in 2023 from 69,069 million in 2022 representing a change of 13.56%. This indicates a better liquidity position.

  Retained Earnings: Retained Earnings increased to 95,774 million in 2023 from 86,156 million in 2022 representing a change of 11.16%. This indicates an accumulated profits.

• 📉 Negative Indicators

  Total Liabilities: Total Liabilities increased to 174,801 million in 2023 from 159,358 million in 2022 representing a change of 9.69%. This indicates an increase in overall liabilities.

  Short Term Investments: Short Term Investments decreased to 4,201 million in 2023 from 4,546 million in 2022 representing a change of -7.59%. This indicates a decrease in short-term investment holdings.

  Total Current Liabilities: Total Current Liabilities increased to 99,054 million in 2023 from 89,237 million in 2022 representing a change of 11.0%. This indicates a higher short-term debt burden.

  Total Debt: Total Debt increased to 62,537 million in 2023 from 57,623 million in 2022 representing a change of 8.53%. This indicates an increase in overall debt burden.

• Quarterly Balance Sheet

Note: The years below are fiscal years in accounting.

	2024Q3	2024Q2	Q/Q change %
0000731766
total assets	299309000000	286056000000	4.63
total liabilities	194854000000	186822000000	4.30
total equity	104455000000	94676000000	10.33
cash and cash equivalents	32400000000	26286000000	23.26
short term investments	4734000000	5037000000	-6.02
long term investments	48689000000	46113000000	5.59
total current assets	92258000000	92038000000	0.24
total non current assets	207051000000	194018000000	6.72
total current liabilities	101565000000	104670000000	-2.97
total non current liabilities	93289000000	63727000000	46.39
common stock	9000000	9000000	0.00
retained earnings	96518000000	92400000000	4.46
total debt	78010000000	75098000000	3.88

Overall Score of Quarterly Balance Sheet

0.67 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Total Assets: Total Assets increased to 299,309 million in 2024Q3 from 286,056 million in 2024Q2 representing a change of 4.63%. Suggesting a growth in asset holdings.

  Total Equity: Total Equity increased to 104,455 million in 2024Q3 from 94,676 million in 2024Q2 representing a change of 10.33%. This indicates an increase in shareholders' equity.

  Cash And Cash Equivalents: Cash And Cash Equivalents increased to 32,400 million in 2024Q3 from 26,286 million in 2024Q2 representing a change of 23.26%. This indicates an increase in available liquid assets.

  Total Current Assets: Total Current Assets increased to 92,258 million in 2024Q3 from 92,038 million in 2024Q2 representing a change of 0.24%. This indicates a better liquidity position.

  Total Current Liabilities: Total Current Liabilities decreased to 101,565 million in 2024Q3 from 104,670 million in 2024Q2 representing a change of -2.97%. This indicates a lower short-term debt burden.

  Retained Earnings: Retained Earnings increased to 96,518 million in 2024Q3 from 92,400 million in 2024Q2 representing a change of 4.46%. This indicates an accumulated profits.

• 📉 Negative Indicators

  Total Liabilities: Total Liabilities increased to 194,854 million in 2024Q3 from 186,822 million in 2024Q2 representing a change of 4.3%. This indicates an increase in overall liabilities.

  Short Term Investments: Short Term Investments decreased to 4,734 million in 2024Q3 from 5,037 million in 2024Q2 representing a change of -6.02%. This indicates a decrease in short-term investment holdings.

  Total Debt: Total Debt increased to 78,010 million in 2024Q3 from 75,098 million in 2024Q2 representing a change of 3.88%. This indicates an increase in overall debt burden.

Cashflow Statements ⓘ

• Annual Cashflow Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000731766
net change in cash	2062000000	1990000000	3.62
operating cash flow	29068000000	26206000000	10.92
free cash flow	25682000000	23404000000	9.73
capital expenditure	-3386000000	-2802000000	-20.84
depreciation and amortization	3972000000	3400000000	16.82
deferred income tax	-245000000	-1004000000	75.60
stock based compensation	1059000000	925000000	14.49
accounts payables	3516000000	1964000000	79.02
inventory	1038000000	0	NaN
acquisitions net	-10136000000	-21458000000	52.76
investments in property plant and equipment	-3386000000	-2802000000	-20.84
net cash used for investing activites	-15574000000	-28476000000	45.31
debt repayment	4280000000	12536000000	-65.86
common stock issued	1353000000	1253000000	7.98
common stock repurchased	-8000000000	-7000000000	-14.29
dividends paid	-6761000000	-5991000000	-12.85
net cash used provided by financing activities	-11529000000	4226000000	-372.81
cash at end of period	25427000000	23365000000	8.83
accounts receivables	-3114000000	-2523000000	-23.42
cash at beginning of period	23365000000	21375000000	9.31

Overall Score of Annual Cashflow Statement

0.56 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Net Change in Cash: Net Change in Cash increased to 2,062 million in 2023 from 1,990 million in 2022 representing a change of 3.62%. Indicating an increased ability to generate cash from the company's operations or its cash flow position.

  Operating Cash Flow: Operating Cash Flow increased to 29,068 million in 2023 from 26,206 million in 2022 representing a change of 10.92%. This indicates that the company generated more cash from its core business operations.

  Free Cash Flow: Free Cash Flow increased to 25,682 million in 2023 from 23,404 million in 2022 representing a change of 9.73%. This indicates an increase in cash generated after accounting for capital expenditures.

  Capital Expenditure: Capital Expenditure decreased to -3,386 million in 2023 from -2,802 million in 2022 representing a change of -20.84%. This indicates a possible improved efficiency or a shift in the company's strategic priorities.

  Accounts Receivables: Accounts Receivables decreased to -3,114 million in 2023 from -2,523 million in 2022 representing a change of -23.42%. This suggests that the company has been able to collect payments from its customers more efficiently and timely.

• 📉 Negative Indicators

  Deferred Income Tax: Deferred Income Tax increased to -245 million in 2023 from -1,004 million in 2022 representing a change of 75.6%. This indicates that the company's tax liability for future periods has increased.

  Stock-Based Compensation: Stock-Based Compensation increased to 1,059 million in 2023 from 925 million in 2022 representing a change of 14.49%. This indicates increased expenses, which is generally considered a negative sign from a financial perspective.

  Accounts Payables: The absolute value of Accounts Payables increased to 3,516 million in 2023 from 1,964 million in 2022 representing a change of 79.02%. This indicates that the company has increased its outstanding obligations to its suppliers.

  Dividends Paid: Dividends Paid decreased to -6,761 million in 2023 from -5,991 million in 2022 representing a change of -12.85%. This indicates a weaker financial position, less confidence in future prospects, and a reluctance to return value to shareholders.

• Quarterly Cashflow Statement

Note: The years below are fiscal years in accounting.

	2024Q3	2024Q2	Q/Q change %
0000731766
operating cash flow	13945000000	6746000000	106.72
free cash flow	12954000000	5893000000	119.82
capital expenditure	-991000000	-853000000	-16.18
depreciation and amortization	1041000000	1020000000	2.06
deferred income tax	124000000	-331000000	137.46
stock based compensation	237000000	222000000	6.76
accounts receivables	2471000000	3691000000	-33.05
accounts payables	0	267000000	-100.00
inventory	0	0	NaN
acquisitions net	-8643000000	-25000000	-34,472.00
investments in property plant and equipment	-991000000	-853000000	-16.18
net cash used for investing activites	-5651000000	-7417000000	23.81
debt repayment	2330000000	1426000000	63.39
common stock issued	867000000	258000000	236.05
common stock repurchased	-956000000	0	NaN
dividends paid	-1937000000	-1935000000	-0.10
net cash used provided by financing activities	-2205000000	-1196000000	-84.36
net change in cash	6114000000	-2128000000	387.31
cash at end of period	32400000000	26286000000	23.26
cash at beginning of period	26286000000	28414000000	-7.49

Overall Score of Quarterly Cashflow Statement

0.67 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Net Change in Cash: Net Change in Cash increased to 6,114 million in 2024Q3 from -2,128 million in 2024Q2 representing a change of 387.31%. Indicating an increased ability to generate cash from the company's operations or its cash flow position.

  Operating Cash Flow: Operating Cash Flow increased to 13,945 million in 2024Q3 from 6,746 million in 2024Q2 representing a change of 106.72%. This indicates that the company generated more cash from its core business operations.

  Free Cash Flow: Free Cash Flow increased to 12,954 million in 2024Q3 from 5,893 million in 2024Q2 representing a change of 119.82%. This indicates an increase in cash generated after accounting for capital expenditures.

  Capital Expenditure: Capital Expenditure decreased to -991 million in 2024Q3 from -853 million in 2024Q2 representing a change of -16.18%. This indicates a possible improved efficiency or a shift in the company's strategic priorities.

  Accounts Payables: The absolute value of Accounts Payables decreased to 0 million in 2024Q3 from 267 million in 2024Q2 representing a change of -100.0%. This indicates that the company has reduced its outstanding obligations to its suppliers.

  Accounts Receivables: Accounts Receivables decreased to 2,471 million in 2024Q3 from 3,691 million in 2024Q2 representing a change of -33.05%. This suggests that the company has been able to collect payments from its customers more efficiently and timely.

• 📉 Negative Indicators

  Deferred Income Tax: Deferred Income Tax increased to 124 million in 2024Q3 from -331 million in 2024Q2 representing a change of 137.46%. This indicates that the company's tax liability for future periods has increased.

  Stock-Based Compensation: Stock-Based Compensation increased to 237 million in 2024Q3 from 222 million in 2024Q2 representing a change of 6.76%. This indicates increased expenses, which is generally considered a negative sign from a financial perspective.

  Dividends Paid: Dividends Paid decreased to -1,937 million in 2024Q3 from -1,935 million in 2024Q2 representing a change of -0.1%. This indicates a weaker financial position, less confidence in future prospects, and a reluctance to return value to shareholders.

Earnings Transcripts ⓘ

We save you time by utilizing Generative AI to summarize earnings transcripts. Our summaries provide a clear insight into the company's current performance, future outlook, and overall sentiment expressed during the call. Click on below links to explore more.

Note: The years mentioned below are fiscal years in accounting.

Q3 2024 Earnings call transcript
Q2 2024 Earnings call transcript
Q1 2024 Earnings call transcript
Q4 2023 Earnings call transcript
Q3 2023 Earnings call transcript
Q2 2023 Earnings call transcript
Q1 2023 Earnings call transcript
Q4 2022 Earnings call transcript

Earnings Per Share (EPS) ⓘ

Analyst Stock Recommendations ⓘ

Discover detailed analyst recommendations for stocks, including categories such as Buy, Hold, Sell, Strong Buy, and Strong Sell. These insights are based on thorough analysis of financial and market factors. The consensus is calculated by assigning a numerical score to each recommendation. These scores are then weighted and averaged over a specified period to provide a comprehensive view of the stock's outlook, with the final score determining the overall consensus.

Financial Ratios ⓘ

• Annual Financial Ratios

	2023-12-31	2022-12-31	Y/Y change %
FY
calendar year	2023	2022	NaN
revenue per share	396.05	344.9	14.83
net income per share	24.12	21.54	11.96
operating cash flow per share	31.32	28.06	11.64
free cash flow per share	27.67	25.06	10.44
cash per share	31.93	29.88	6.84
book value per share	106.59	92.45	15.30
tangible book value per share	-21.56	-22.92	5.93
shareholders equity per share	95.64	83.27	14.86
interest debt per share	70.89	63.93	10.87
market cap	488564160000	495188120000.0	-1.34
enterprise value	525674160000	529446120000.0	-0.71
pe ratio	21.83	24.61	-11.30
price to sales ratio	1.33	1.54	-13.53
pocfratio	16.81	18.9	-11.05
pfcf ratio	19.02	21.16	-10.09
pb ratio	5.5	6.37	-13.55
ptb ratio	5.5	6.37	-13.55
ev to sales	1.43	1.64	-12.98
enterprise value over ebitda	16.17	16.63	-2.79
ev to operating cash flow	18.08	20.2	-10.49
ev to free cash flow	20.47	22.62	-9.52
earnings yield	0.05	0.04	12.75
free cash flow yield	0.05	0.05	11.22
debt to equity	0.7	0.74	-4.90
debt to assets	0.23	0.23	-2.58
net debt to ebitda	1.14	1.08	6.05
current ratio	0.79	0.77	2.31
interest coverage	9.97	13.59	-26.66
income quality	1.3	1.27	2.29
dividend yield	0.01	0.01	14.38
payout ratio	0.3	0.3	1.45
sales general and administrative to revenue	0	0	NaN
research and ddevelopement to revenue	0	0	NaN
intangibles to total assets	0.43	0.44	-0.93
capex to operating cash flow	0.12	0.11	8.94
capex to revenue	0.01	0.01	5.91
capex to depreciation	0.85	0.82	3.44
stock based compensation to revenue	0.0	0.0	0.34
graham number	227.81	200.9	13.40
roic	0.17	0.16	3.34
return on tangible assets	0.14	0.15	-0.87
graham net net	-124.94	-116.28	-7.44
working capital	-20617000000	-20168000000	-2.23
tangible asset value	-20007000000	-21406000000	6.54
net current asset value	-96364000000	-90289000000	-6.73
invested capital	109759000000	97713000000	12.33
average receivables	34710000000	29266000000	18.60
average payables	44364500000	52948500000	-16.21
average inventory	0	0	NaN
days sales outstanding	38.7	34.5	12.17
days payables outstanding	41.56	84.73	-50.95
days of inventory on hand	0	0	NaN
receivables turnover	9.43	10.58	-10.85
payables turnover	8.78	4.31	103.88
inventory turnover	0	0	NaN
roe	0.25	0.26	-2.53
capex per share	3.65	3	21.62

• Neutral

  ROE: Return on Equity (ROE) decreased to 0.25 on 2023-12-31 from 0.26 on 2022-12-31, representing a change of -2.53%. However, ROE is >= 15%, suggesting that the company has been generating high returns for its shareholders still.

• Negative

  PE Ratio: Price-to-Earnings (P/E) Ratio decreased to 21.83 on 2023-12-31 from 24.61 on 2022-12-31, representing a change of -11.30%. Indicating a decrease in the relative valuation of the company's stock.

  Current Ratio: Current Ratio increased to 0.79 on 2023-12-31 from 0.77 on 2022-12-31, representing a change of 2.31%. The current ratio has been increasing, suggesting an increase in the company's short-term liquidity. However, it's below 1, indicating potential liquidity issues.

• Positive

  Debt-to-Equity Ratio: Debt-to-Equity Ratio decreased to 0.70 on 2023-12-31 from 0.74 on 2022-12-31, representing a change of -4.90%. The debt-to-equity ratio has been decreasing, indicating that the company has been relying less on debt financing. A ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

• Quarterly Financial Ratios

	2024-09-30 Q3	2024-06-30 Q2	Q/Q change %
UNH
calendar year	2024	2024	NaN
revenue per share	109.23	106.25	2.80
net income per share	6.56	4.58	43.31
operating cash flow per share	15.11	7.32	106.27
free cash flow per share	14.03	6.4	119.34
cash per share	40.23	34.01	18.29
book value per share	113.17	107.75	5.03
tangible book value per share	-27.21	-22.73	-19.74
shareholders equity per share	108.21	92.07	17.53
interest debt per share	85.68	82.61	3.72
market cap	539659640000.0	455572650000	18.46
enterprise value	585269640000	504384650000	16.04
pe ratio	22.28	27.01	-17.52
price to sales ratio	5.35	4.66	14.98
pocfratio	38.7	67.53	-42.70
pfcf ratio	41.66	77.31	-46.11
pb ratio	5.4	5.37	0.57
ptb ratio	5.4	5.37	0.57
ev to sales	5.81	5.15	12.63
enterprise value over ebitda	60.16	65.76	-8.52
ev to operating cash flow	41.97	74.77	-43.87
ev to free cash flow	45.18	85.59	-47.21
earnings yield	0.01	0.01	21.24
free cash flow yield	0.02	0.01	85.57
debt to equity	0.78	0.89	-11.81
debt to assets	0.26	0.26	-0.72
net debt to ebitda	4.69	6.36	-26.34
current ratio	0.91	0.88	3.30
interest coverage	8.11	7.99	1.41
income quality	2.3	1.6	43.93
dividend yield	0.0	0.0	-15.49
payout ratio	0.32	0.46	-30.30
sales general and administrative to revenue	0	0	NaN
research and ddevelopement to revenue	0	0	NaN
intangibles to total assets	0.43	0.42	3.05
capex to operating cash flow	0.07	0.13	-43.80
capex to revenue	0.01	0.01	12.76
capex to depreciation	0.95	0.84	13.83
stock based compensation to revenue	0.0	0.0	3.62
graham number	126.38	97.38	29.78
roic	0.04	0.04	4.68
return on tangible assets	0.04	0.03	40.37
graham net net	-132.29	-128.22	-3.18
working capital	-9307000000	-12632000000	26.32
tangible asset value	-25117000000	-20931000000	-20.00
net current asset value	-102596000000	-94784000000	-8.24
invested capital	130404000000	117334000000	11.14
average receivables	48681000000	48179000000	1.04
average payables	31716500000	64101500000	-50.52
average inventory	0	-37447500000	100.00
days sales outstanding	42.39	45.87	-7.59
days payables outstanding	0	74.34	-100.00
days of inventory on hand	0	0	NaN
receivables turnover	2.12	1.96	8.22
payables turnover	0	1.21	-100.00
inventory turnover	0	0	NaN
roe	0.06	0.05	21.94
capex per share	1.07	0.93	15.93

• ROE:

• Negative

  PE Ratio: Price-to-Earnings (P/E) Ratio decreased to 22.28 on 2024-09-30 Q3 from 27.01 on 2024-06-30 Q2, representing a change of -17.52%. Indicating a decrease in the relative valuation of the company's stock.

  Current Ratio: Current Ratio increased to 0.91 on 2024-09-30 Q3 from 0.88 on 2024-06-30 Q2, representing a change of 3.30%. The current ratio has been increasing, suggesting an increase in the company's short-term liquidity. However, it's below 1, indicating potential liquidity issues.

• Positive

  Debt-to-Equity Ratio: Debt-to-Equity Ratio decreased to 0.78 on 2024-09-30 Q3 from 0.89 on 2024-06-30 Q2, representing a change of -11.81%. The debt-to-equity ratio has been decreasing, indicating that the company has been relying less on debt financing. A ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

Growth Rates ⓘ

• Annual Growth

• Quarterly Growth

Intrinsic Value (Discounted Cash Flow) ⓘ

Positive Sentiment: Discounted Cash Flow value is 887.58 which is higher than current price 605.23, indicates the company may be undervalued.